Omega-3 fatty acids are one of the most used food supplements. However, atrial fibrillation has been recently presented as a rare adverse drug event following ingestion of high doses of this food supplement.
References
[1]
Jin, M.J. and Kim, J.K. (2021) Customer Adoption Factors for In-Flight Entertainment and Connectivity. Research in Transportation Business & Management, Article ID: 100759. (In Press) https://doi.org/10.1016/j.rtbm.2021.100759
[2]
Albert, C.M., Cook, N.R., Pester, J., et al. (2021) Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA, 325, 1061-1073. https://doi.org/10.1001/jama.2021.1489
[3]
García-Cortés, M., Lucena, M.I., Pachkoria, K., Borraz, Y., Hidalgo, R., Andrade, R.J. and Spanish Group for the Study of Drug-Induced Liver Disease (2008) Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Geham. Alimentary Pharmacology and Therapeutics, 27, 780-789. https://doi.org/10.1111/j.1365-2036.2008.03655.x
[4]
Kris-Etherton, P.M., Harris, W.S. and Appel, L.J. (2002) Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease. Circulation, 106, 2747-2757. https://doi.org/10.1161/01.CIR.0000038493.65177.94
[5]
Skulas-Ray, A.C., Wilson, P.W., Harris, W.S., Brinton, E.A., Kris-Etherton, P.M., Richter, C.K., Jacobson, T.A., Engler, M.B., Miller, M., Robinson, J.G. and Blum, C.B. (2019) Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory from the American Heart Association. Circulation, 140, e673-e691. https://doi.org/10.1161/CIR.0000000000000709
[6]
Nicholls, S.J., Lincoff, A.M., Garcia, M., Bash, D., Ballantyne, C.M., Barter, P.J., Davidson, M.H., Kastelein, J.J., Koenig, W., McGuire, D.K. and Mozaffarian, D. (2020) Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA, 324, 2268-2280. https://doi.org/10.1001/jama.2020.22258
[7]
Bhatt, D.L., Steg, P.G., Miller, M., Brinton, E.A., Jacobson, T.A., Ketchum, S.B., Doyle Jr., R.T., Juliano, R.A., Jiao, L., Granowitz, C. and Tardif, J.C. (2019) Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine, 380, 11-22. https://doi.org/10.1056/NEJMoa1812792
[8]
Kalstad, A.A., Myhre, P.L., Laake, K., Tveit, S.H., Schmidt, E.B., Smith, P., Nilsen, D.W.T., Tveit, A., Fagerland, M.W., Solheim, S. and Seljeflot, I. (2021) Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized, Controlled Trial. Circulation, 143, 528-539. https://doi.org/10.1161/CIRCULATIONAHA.120.052209
